Nagane, M., Kobayashi, K., Saito, K., Shimizu, S., Suematsu, S., Kume, S., . . . Shiokawa, Y. (2018). ACTR-48. FEASIBILITY OF DISCONTINUATION OF ADJUVANT TEMOZOLOMIDE AFTER 12 CYCLES REMAINING WITHOUT PROGRESSION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro Oncol.

Nagane, Motoo, Keiichi Kobayashi, Kuniaki Saito, Saki Shimizu, Shinya Suematsu, Satoshi Kume, Yuma Okamura, και Yoshiaki Shiokawa. "ACTR-48. FEASIBILITY OF DISCONTINUATION OF ADJUVANT TEMOZOLOMIDE AFTER 12 CYCLES REMAINING WITHOUT PROGRESSION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2018.

Nagane, Motoo, et al. "ACTR-48. FEASIBILITY OF DISCONTINUATION OF ADJUVANT TEMOZOLOMIDE AFTER 12 CYCLES REMAINING WITHOUT PROGRESSION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2018.